Ohsu Night Cancer Institute - OR Washington, Beaverton 97006

Ohsu Night Cancer Institute entered the industry of Oncologists in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of $5.000.000 to $9.999.999. The NAICS classifies this business under the code 6211110, which describes it as a Oncologists. For further clarification, the SIC classifies this business under the code 8011 and described it as a Oncologists. The business provides service to the B2C market.

To acquire more information, please contact Dianne Price, Office Manager by calling (503) 203-1000 during business hours. You can also write to the business’ Single Location at 15700 Sw Greystone Court, Beaverton, Oregon OR 97006. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Ohsu Night Cancer Institute
Representative: Dianne Price, Office Manager
Place of Business: 15700 Sw Greystone Court, Beaverton, OR 97006
Contact Number: (503) 203-1000
Type of Service: Oncologists
SIC Number: 8011
NAICS Number: 6211110
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 2010
Income/Year: $5.000.000 to $9.999.999
Laborers: 1 to 4
Share This Company:

Ohsu Night Cancer Institute is a company operating from Washington, Oregon providing professional Oncologists and relevant B2C variables. It was founded in 2010 and registered with the SIC code 8011 as Oncologists, and with the NAICS code 6211110 as Oncologists.

With a current employee count of 1 to 4, Ohsu Night Cancer Institute has gone to report making $5.000.000 to $9.999.999 per annum on its journey towards growth. This company invites you to contact its representative Dianne Price, Office Manager at (503) 203-1000 for related queries, or to locate its Single Location using the coordinates 45.51366,-122.83828.

The Single Location can also be found at the street address 15700 Sw Greystone Court in Beaverton, Oregon 97006 and can be engaged online through the company website at , the company Twitter , and Facebook page .